The article discusses that the administration of prophylactic and therapeutic heparin to pregnant women with a current or past history of venous thromboembolism (VTE). Topics discussed include Inclusion criteria were pregnant women who received prenatal care, were managed with LMWH, were switched to UFH during pregnancy; and Women were excluded if they delivered outside UI Health or if they delivered prior to 24 weeks of gestation.